Quick Contact
Maria Colombino
Experience & Activities
Genetic Instability Markers in Cancer. Palmieri G, Casula M, Manca A, Palomba G, Sini MC, Doneddu V, Cossu A, Colombino M.Methods Mol Biol. 2020;2055:133-154. doi: 10.1007/978-1-4939-9773-2_6. PMID: 31502150
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients. Colombino M, Rozzo C, Paliogiannis P, Casula M, Manca A, Doneddu V, Fedeli MA, Sini MC, Palomba G, Pisano M, Ascierto PA, Caracò C, Lissia A, Cossu A, Palmieri G. J Clin Med. 2020 Jul 30;9(8):2430. doi: 10.3390/jcm9082430. PMID: 32751423
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma.Colombino M, Paliogiannis P, Cossu A, Santeufemia DA; Sardinian Lung Cancer (SLC) Study Group, Sini MC, Casula M, Palomba G, Manca A, Pisano M, Doneddu V, Palmieri G. BMC Pulm Med. 2019 Nov 11;19(1):209. doi: 10.1186/s12890-019-0964-x. PMID: 31711449
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches. Palmieri G, Colombino M, Casula M, Manca A, Mandalà M, Cossu A; Italian Melanoma Intergroup (IMI). Curr Oncol Rep. 2018 Sep 14;20(11):86. doi: 10.1007/s11912-018-0733-7. PMID: 30218391
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. Colombino M, Capone M, Lissia A, Cossu A, Rubino C, De Giorgi V, Massi D, Fonsatti E, StaibanoS, Nappi O, Pagani E, Casula M, Manca A, Sini M, Franco R, Botti G, Caracò C, Mozzillo N, Ascierto PA, Palmieri G. J Clin Oncol. 2012 Jul 10;30(20):2522-9.doi: 10.1200/JCO.2011.41.2452. PMID: 22614978
SEDE SECONDARIA DI SASSARI
maria.colombino@cnr.it – colombinom@yahoo.it
PEC: colombinom@pec.it
Scopus Author Identifier: 6602522509
Orcid: https://orcid.org/0000-0001-8051-3356
Web of Science ResearcherID: AAX-7371-2020
